AZN - AstraZeneca PLC
This page shows which of the focused investors we track hold AZN and how their positions changed, so you can see how much conviction the group has in the stock.
In Q3 2021 it was held by 4 managers with an aggregate reported value of $74.45M, which is 0.01% of the combined portfolio.
As of Q3 2021, 4 tracked institutional managers held AZN (AstraZeneca PLC) with an aggregate reported value of $74.45M — 0.01% of the combined AlphaBaseline portfolio.
Get email alerts when a tracked manager trades AZN — sign in or create a free account.
- Source
- Curated SEC 13F filings
- Period
- Q3 2021
- Ticker
- AZN
13F data is delayed and excludes shorts/non-13F assets.
Holders
| 1 | Dodge & Cox - Dodge & Cox | 0.03% | Reduce -3.5% | 843,865 | $50.68M |
| 2 | Sarah Ketterer - Causeway Capital Management | 0.47% | Add +104.4% | 347,011 | $20.84M |
| 3 | Ariel Investments - Ariel Investments | 0.01% | Reduce -0.3% | 26,347 | $1.58M |
| 4 | Lee Ainslie - Maverick Capital | 0.01% | Reduce -7.3% | 22,369 | $1.34M |
Loading holder history for AZN…